Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Tacoma, WA
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Charleston, WV
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Charleston, WV
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Broadmeadow,
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Broadmeadow,
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Buena Park, CA
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Buena Park, CA
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Fort Myers, FL
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Gainesville, FL
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Saint Cloud, FL
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Saint Cloud, FL
Click here to add this to my saved trials
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  8/29/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 8/29/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
Indiana University
mi
from
Indianapolis, IN
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
University of Iowa
mi
from
Iowa City, IA
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
University of Michigan
mi
from
Ann Arbor, MI
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
San Francisco, CA
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Chicago, IL
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Baltimore, MD
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Boston, MA
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Worcester, MA
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Newark, NJ
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
New York, NY
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
Seattle, WA
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated:  8/31/2017
mi
from
Toronto,
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis
Status: Enrolling
Updated: 8/31/2017
mi
from
Toronto,
Click here to add this to my saved trials
Topical Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis
A Single Center, Randomized, Double-Blind Controlled Study of Topical Endoluminal Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis
Status: Enrolling
Updated:  9/6/2017
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Topical Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis
A Single Center, Randomized, Double-Blind Controlled Study of Topical Endoluminal Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis
Status: Enrolling
Updated: 9/6/2017
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Preoperative Etanercept Before Inguinal Hernia Surgery
A Randomized Controlled Study Evaluating Pre-operative Etanercept on the Severity of Postoperative Pain After Inguinal Hernia Surgery.
Status: Enrolling
Updated:  9/6/2017
Walter Reed Army Medical Center
mi
from
Washington, D.C.,
Preoperative Etanercept Before Inguinal Hernia Surgery
A Randomized Controlled Study Evaluating Pre-operative Etanercept on the Severity of Postoperative Pain After Inguinal Hernia Surgery.
Status: Enrolling
Updated: 9/6/2017
Walter Reed Army Medical Center
mi
from
Washington, D.C.,
Click here to add this to my saved trials
TMS Treatment for Pain in Chronic Pancreatitis
The Effect of 10-Day Treatment of Repetitive Transcranial Magnetic Stimulation on Abdominal Pain in Patients With Chronic Pancreatitis
Status: Enrolling
Updated:  9/11/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
TMS Treatment for Pain in Chronic Pancreatitis
The Effect of 10-Day Treatment of Repetitive Transcranial Magnetic Stimulation on Abdominal Pain in Patients With Chronic Pancreatitis
Status: Enrolling
Updated: 9/11/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women With Breast Cancer Following Initiation of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  9/12/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women With Breast Cancer Following Initiation of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 9/12/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Alliance Clinical Research
mi
from
Oceanside, CA
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Alliance Clinical Research
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Clinical Research of the Rockies
mi
from
LaFayette, CO
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Clinical Research of the Rockies
mi
from
LaFayette, CO
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Gastroenterology Consultants of Clearwater
mi
from
Clearwater, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Gastroenterology Consultants of Clearwater
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
West Coast Endoscopy Center
mi
from
Clearwater, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
West Coast Endoscopy Center
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Clinical Research of West Florida
mi
from
Clearwater, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Gastroenterology Group of Naples
mi
from
Naples, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Gastroenterology Group of Naples
mi
from
Naples, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Gulfshore Endoscopy Center (Endoscopies Only)
mi
from
Naples, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Gulfshore Endoscopy Center (Endoscopies Only)
mi
from
Naples, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
North Florida Gastroenterology Research, LLC
mi
from
Orange Park, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
North Florida Gastroenterology Research, LLC
mi
from
Orange Park, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Internal Medicine Specialists
mi
from
Orlando, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Internal Medicine Specialists
mi
from
Orlando, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
East Ann Arbor Health and Geriatrics Center
mi
from
Ann Arbor, MI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
East Ann Arbor Health and Geriatrics Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
University of Michigan Health Systems
mi
from
Ann Arbor, MI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Center for Digestive Health
mi
from
Troy, MI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Center for Digestive Health
mi
from
Troy, MI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Surgical Centers of Michigan
mi
from
Troy, MI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Surgical Centers of Michigan
mi
from
Troy, MI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
NYU Langone Nassau Gastroenterology Associates
mi
from
Great Neck, NY
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
NYU Langone Nassau Gastroenterology Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Cleveland Clinic
mi
from
Cleveland, OH
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Great Lakes Gastroenterology
mi
from
Mentor, OH
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Great Lakes Gastroenterology
mi
from
Mentor, OH
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
The Endoscopy Center of Lake County
mi
from
Mentor, OH
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
The Endoscopy Center of Lake County
mi
from
Mentor, OH
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Great Lakes Gastroenterology
mi
from
Willoughby, OH
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Great Lakes Gastroenterology
mi
from
Willoughby, OH
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Endoscopy Center of Tyler
mi
from
Tyler, TX
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Endoscopy Center of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
University of Utah HSC
mi
from
Salt Lake City, UT
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
University of Utah HSC
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Wisconsin Center for Advanced Research - GI Associates, LLC
mi
from
Milwaukee, WI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Wisconsin Center for Advanced Research - GI Associates, LLC
mi
from
Milwaukee, WI
Click here to add this to my saved trials